Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Rare Bleeding Disorders in Women — Still Underdiagnosed, Still Undertreated.
An excellent presentation by Saskia Schols at this year’s EAHAD congress highlighted a critical and often overlooked dimension of Rare Bleeding Disorders (RBDs): the disproportionate burden on women and girls.
Bleeding phenotype across RBDs
From fibrinogen disorders to FVII, FX, FXI and FXIII deficiency, the most common symptoms include mucocutaneous bleeding, epistaxis, postoperative bleeding — and consistently: heavy menstrual bleeding (HMB) and postpartum haemorrhage (PPH).
Even mild fibrinogen disorders (hypofibrinogenemia, dysfibrinogenemia) carry a bleeding grade severity ≥1 in the majority of patients.
A diagnostic gap that cannot be ignored
- Median age at RBD diagnosis: 28 years — with a diagnostic delay of ~14 years from menarche
- Women/girls may have normal PT and APTT — standard tests miss the bleeding
- Approximately 80% required treatment; 30% absent from work/school >2×/year
Using the right bleeding assessment tool — ISTH BAT, EN-RBD BSS, or Bleeding Severity Score — for the right patient makes all the difference.
Women with RBDs deserve earlier diagnosis and tailored care.
Thank you Saskia for this important message!”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis